NASDAQ:TWST Twist Bioscience (TWST) Stock Price, News & Analysis $188.67 +0.62 (+0.33%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$189.10 +0.44 (+0.23%) As of 10/2/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Twist Bioscience Stock (NASDAQ:TWST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Twist Bioscience alerts:Sign Up Key Stats Today's Range$183.39▼$198.1050-Day Range$85.47▼$193.2452-Week Range$23.30▼$200.31Volume2.08 million shsAverage Volume2.20 million shsMarket Capitalization$11.83 billionP/E RatioN/ADividend YieldN/APrice Target$115.27Consensus RatingModerate Buy Company Overview Twist Bioscience Corporation (NASDAQ:TWST) is a biotechnology company that develops and manufactures synthetic DNA using a silicon-based production platform. Its technology is designed to enable the precise, high-throughput synthesis of DNA at smaller scale and with potentially lower material consumption than traditional methods. The company provides synthetic DNA products and services for applications in drug discovery and development, biotechnology research, agriculture, industrial chemicals and other life sciences markets. Its offerings include synthetic genes, oligonucleotides, gene fragments, variant libraries and next-generation sequencing target-enrichment products. Twist also supports data-storage research and other emerging applications for synthetic biology. Twist Bioscience was founded in 2013 and is headquartered in South San Francisco, California. The company serves customers globally through its commercial operations and online ordering platform. Co-founder Emily M. Leproust has served as chief executive officer since the company’s founding.AI Generated. May Contain Errors. Read More Twist Bioscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreTWST MarketRank™: Twist Bioscience scored higher than 23% of companies evaluated by MarketBeat, and ranked 784th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingTwist Bioscience has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and 2 sell ratings.Downside RiskTwist Bioscience has a consensus price target of $115.27, representing about 38.9% downside from its current price of $188.67.Amount of Analyst CoverageTwist Bioscience has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Twist Bioscience's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Twist Bioscience are expected to grow in the coming year, from ($2.12) to ($1.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Twist Bioscience is -84.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Twist Bioscience is -84.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTwist Bioscience has a P/B Ratio of 24.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Twist Bioscience's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted20.58% of the float of Twist Bioscience has been sold short.Short Interest Ratio / Days to CoverTwist Bioscience has a short interest ratio ("days to cover") of 8.92.Change versus previous monthShort interest in Twist Bioscience has recently increased by 3.65%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTwist Bioscience does not currently pay a dividend.Dividend GrowthTwist Bioscience does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.22 News SentimentTwist Bioscience has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Twist Bioscience this week, compared to 6 articles on an average week.Search InterestOnly 12 people have searched for TWST on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows6 people have added Twist Bioscience to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Twist Bioscience insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $78,416,543.00 in company stock.Percentage Held by Insiders3.08% of the stock of Twist Bioscience is held by insiders.Percentage Held by InstitutionsTwist Bioscience has minimal institutional ownership at this time.Read more about Twist Bioscience's insider trading history. Receive TWST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TWST Stock News HeadlinesTwist Bioscience (TWST) Stock Could Be Reasonable On Its 9x Three Year RunOctober 2 at 1:32 PM | finance.yahoo.comTwist Bioscience (TWST) Stock Fair Value Edges Higher As Analysts Split On AI UpsideOctober 2 at 1:32 PM | finance.yahoo.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 4 at 1:00 AM | Stansberry Research (Ad)Twist Bioscience Corporation (NASDAQ:TWST) Stock Rated "Moderate Buy" by Sell-Side BrokeragesSeptember 30, 2026 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 5,203 Shares of Company StockSeptember 26, 2026 | insidertrades.comTwist Bioscience (NASDAQ:TWST) SVP Paula Green Sells 294 Shares of StockSeptember 24, 2026 | insidertrades.comTwist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 356,546 Shares of StockSeptember 22, 2026 | insidertrades.comTwist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 412 SharesSeptember 11, 2026 | insidertrades.comSee More Headlines TWST Stock Analysis - Frequently Asked Questions How have TWST shares performed this year? Twist Bioscience's stock was trading at $31.72 at the beginning of 2026. Since then, TWST stock has increased by 494.8% and is now trading at $188.67. How were Twist Bioscience's earnings last quarter? Twist Bioscience Corporation (NASDAQ:TWST) issued its earnings results on Monday, August, 3rd. The company reported ($0.56) EPS for the quarter, missing analysts' consensus estimates of ($0.51) by $0.05. The company's quarterly revenue was up 23.2% on a year-over-year basis. Read the conference call transcript. When did Twist Bioscience IPO? Twist Bioscience (TWST) raised $75 million in an initial public offering on Wednesday, October 31st 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Cowen acted as the underwriters for the IPO and Allen & Company and Baird were co-managers. How do I buy shares of Twist Bioscience? Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Twist Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Twist Bioscience investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings8/03/2026Today10/04/2026Next Earnings (Estimated)11/13/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (8m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 TWST's financial health is in the Green zone, according to TradeSmith. TWST has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:TWST CIK1581280 Webwww.twistbioscience.com Phone(800) 719-0671FaxN/AEmployees979Year Founded2013Price Target and Rating Average Price Target for Twist Bioscience$115.27 High Price Target$212.00 Low Price Target$41.00 Potential Upside/Downside-38.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($2.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$77.67 million Net Margins-31.66% Pretax Margin-31.46% Return on Equity-28.64% Return on Assets-19.94% Debt Debt-to-Equity Ratio0.03 Current Ratio2.67 Quick Ratio2.38 Sales & Book Value Annual Sales$376.57 million Price / Sales31.42 Cash FlowN/A Price / Cash FlowN/A Book Value$7.84 per share Price / Book24.07Miscellaneous Outstanding Shares62,710,000Free Float60,776,000Market Cap$11.83 billion OptionableOptionable Beta2.19 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:TWST) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TWST Stock Alerts